Low cost insulin program available to Wyoming citizens
by Office of the Attorney General
January 30, 2025
As announced in October, Attorney General Bridget Hill reminded Wyoming citizens of the settlement agreement with Sanofi-Aventis U.S. LLC (Sanofi), which guarantees that Wyoming citizens not enrolled in government health care programs can buy Sanofi’s insulin products for $35 per month for the next five years and directed citizens to a website to help them enroll in the program.
The terms of this settlement are now in effect. and Wyoming has launched a website for Wyoming consumers to obtain low-cost insulin as a result of the settlement. The settlement requires Sanofi to provide insulin products—including Admelog, Lantus, Toujeo, and Apidra, and any biosimilar of those products that Sanofi markets in the U.S.—at $35 per monthly prescription for customers choosing to pay with cash.
To take advantage of the pricing, consumers will need to register for a savings card via Sanofi. Consumers can find all links and necessary information at the following website: https://attorneygeneral.wyo.gov/law-office-division/consumer-protection-and-antitrust-unit/sanofi-insulinsettlement
In addition to the $35 monthly prescription rate, Sanofi has agreed to implement an enrollment message program to assist pharmacists and patients in determining eligibility for its low-cost insulin. The system will alert patients about this low-cost alternative at pharmacy counters throughout the State when patients are filling their prescriptions. Lastly, Sanofi has also committed to continuing its Patient Connection Program that provides free insulin to Wyoming citizens in financial need. Wyoming consumers can sign up for this Patient Connection Program at the following website: https://www.sanofipatientconnection.com/patientassistance-connection
|
